Astrazeneca Plc stock is traded at $175.41, with a volume of 2,581,073. It is down -1.87% in the last 24 hours and up +3.90% over the past month. A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Previous Close:
$178.76
Open:
$177.10
24h Volume:
2,581,073
Relative Volume:
1.20
Market Cap:
$272.05B
Revenue:
$60.48B
Net Income/Loss:
$10.40B
P/E Ratio:
52.68
EPS:
$3.33
Net Cash Flow:
$8.05B
1W Performance:
-4.90%
1M Performance:
+3.90%
6M Performance:
-6.43%
1Y Performance:
-1.10%
1-Day Range:
$174.03$178.29
1-Week Range:
$174.03$187.69
52-Week Range:
$153.41$212.71
Astrazeneca Plc Stock (AZN) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS